Skip to content

Dexmedetomidine Influence on the Level of Perioperative Blood Glucose and Insulin of Elderly Diabetes Patients

Status
UNKNOWN
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02154074
Enrollment
92
Registered
2014-06-03
Start date
2014-05-31
Completion date
2014-10-31
Last updated
2014-06-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Perioperative Blood Glucose and Insulin

Keywords

Dexmedetomidine perioperative blood glucose and insulin

Brief summary

Dexmedetomidine is a kind of high selectivity alpha 2 agonists adrenaline, can inhibit the activity of sympathetic nerve, alleviate pain,and improve cardiovascular stability in the operation period. Dexmedetomidine have influence on perioperative stress response and immune function,but it is not clear.

Interventions

general anesthesia induction: midazolam 0.1mg/Kg, sufentanil 1ug/Kg, cisatracurium 0.15mg/Kg, and then immediatly administrate etomidate 0.2 mg/Kg

DRUGIsoflurane

inhale Isoflurane 1.5MAC

DRUGDexmedetomidine

anesthesia induction period: intravenous pumping Dexmedetomidine 4ug/Kg/h; after 10 minutes,turn to 0.4ug/Kg/h.

DRUGnormal saline

the same volume of saline + Isoflurane during operation

Sponsors

Second Affiliated Hospital of Xi'an Jiaotong University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
60 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

* Aged 60 to 80 years old; * Type 2 diabetes; * Not use insulin treatment; * Onging general anesthesia surgery; * Surgery time 1-3 hours

Exclusion criteria

* ASA classification \> class II; * Hypertension; * Serious central nervous system diseases (acute stroke, uncontrolled seizures, -Severe dementia); * Unstable angina and acute myocardial infarction; * Allergy to investigational drug; * Hepatic and renal dysfunction

Design outcomes

Primary

MeasureTime frameDescription
blood glucosefrom the day before surgery to 24 hours after surgerymeasure blood glucose at 3 time points,the day before surgery,Intraoperative(1 hour after surgery begain),one day after surgery(24 hours after surgery); examine the concentration of blood glucose in serum.
level of blood insulinfrom the day before surgery to 24 hours after surgerymeasure the level of blood insulin at 3 time points,the day before surgery,Intraoperative(1 hour after surgery begain),one day after surgery(24 hours after surgery); use ELISA to examine the concentration of blood insulin in serum.

Secondary

MeasureTime frameDescription
vital signsduration of perioperative periodmeasure the blood pressure(BP),heart rate(HR) and oxygen saturation(SpO2) in the perioperative period

Countries

China

Contacts

Primary ContactHongtao Liu
lannylouis@163.com13572225310

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026